We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Keywords » Drug Pipeline Alert

Items Tagged with 'Drug Pipeline Alert'

ARTICLES

Pharma Blog Watch

April 13, 2007

FDA Approves Ranbaxy's Generic Claritin

April 13, 2007

Ohm Laboratories, a wholly owned subsidiary of Ranbaxy Laboratories, announced it has received FDA approval to manufacture and commercialize its generic loratadine orally disintegrating tablets, 10 mg.

Read More

GSK Announces FDA Approval of Antibacterial Ointment

April 13, 2007

GlaxoSmithKline (GSK) announced that the FDA has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.

Read More

FDA Advisory Committee Rejects Merck's Arcoxia

April 13, 2007

The FDA's Arthritis Advisory Committee voted 20-1 against recommending approval of Merck's Arcoxia, a potential successor to Vioxx as a treatment for arthritis pain.

Read More

Roche Presents Efficacy and Safety Data on Mircera in CKD

April 13, 2007

Roche presented data analyses from a large registration trial program to provide efficacy and safety information on Mircera for the treatment of renal anemia associated with chronic kidney disease (CKD) at the National Kidney Foundation Spring Clinical Meeting.

Read More

Stem Cell Therapeutics Announces Interim Results From Stroke Study

April 13, 2007

Stem Cell Therapeutics has announces positive interim results from its Phase IIa study of Beta-hCG plus erythropoietin (EPO) in acute stroke.

Read More

Idenix Reports Results From Two Hepatitis C Studies

April 13, 2007

Idenix Pharmaceuticals has announced results from two Phase IIb studies of the novel combination of valopicitabine and Pegasys in both treatment-naive and treatment-experienced patients infected with the genotype-1 strain of the hepatitis C virus (HCV).

Read More

Pharmaxis Begins Trial of Bronchitol in CF

April 13, 2007

Pharmaxis has announced the launch of a Phase III trial of Bronchitol that is being conducted initially in 40 hospitals across Australia, the UK and Ireland.

Read More

Dyax Reports Positive Findings From HAE Study

April 13, 2007

Dyax has announced positive topline results from its Phase III, placebo-controlled trial, EDEMA3, for its lead product candidate DX-88, for hereditary angioedema (HAE).

Read More

Advanced Magnetics Presents Data on Iron Replacement Therapy

April 13, 2007

Advanced Magnetics announced positive results from two additional Phase III clinical trials of ferumoxytol as an intravenous (IV) iron replacement therapeutic.

Read More
More Articles Tagged with 'Drug Pipeline Alert'

Upcoming Events

  • 01Feb

    The Future of QMS: Will the Recent Announcement and Delays Have a Global Impact?

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • NeuroMetrix Launches DPNCheck 2.0 for Peripheral Neuropathy Screening

  • Syros Gets Fast Track Status for Higher-Risk Myelodysplastic Syndrome Candidate

  • FDA Approves Abbott’s Spinal Cord Stimulation System for Diabetic Peripheral Neuropathy

  • FDA Expands Approval for Merck’s Keytruda in NSCLC

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing